Page last updated: 2024-08-21

aminoimidazole carboxamide and Arteriosclerosis, Coronary

aminoimidazole carboxamide has been researched along with Arteriosclerosis, Coronary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, GY; Liu, DX; Wang, F; Yu, J; Zhang, DS1
Ambrosio, G; Ferguson, TB; Harrington, RA; Koglin, J; Lira, A; Newman, MF; Nussmeier, NA; Pearl, RG; Pitt, B; Reece, TL; Wechsler, AS; Weisel, RD; White, JA1

Trials

1 trial(s) available for aminoimidazole carboxamide and Arteriosclerosis, Coronary

ArticleYear
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
    JAMA, 2012, Jul-11, Volume: 308, Issue:2

    Topics: Adenosine; Aged; Aminoimidazole Carboxamide; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Perioperative Period; Reperfusion Injury; Ribonucleosides; Stroke; Ventricular Dysfunction, Left

2012

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Arteriosclerosis, Coronary

ArticleYear
Role of Phosphorylated AMP-Activated Protein Kinase (AMPK) in Myocardial Insulin Resistance After Myocardial Ischemia-Reperfusion During Cardiopulmonary Bypass Surgery in Dogs.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Jun-04, Volume: 25

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardioplegic Solutions; Cardiopulmonary Bypass; China; Coronary Artery Disease; Dogs; Female; Glucose; Glucose Transporter Type 4; Heart Ventricles; Insulin Resistance; Ischemia; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Pyrazoles; Pyrimidines; Ribonucleotides

2019